EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies

Lisa Wein, Carolin Ertl, Kai Rejeski, Richard David-Rus, Mingzi Kong-Bild, Rebecca Pusl, Lisa Frölich, Dirk Tomsitz, Louisa von Baumgarten, Marion Subklewe, Lucie Heinzerling

European Journal of Cancer · 2026-12 · 249 · 117817

DOI: 10.1016/j.ejca.2026.117817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-12. Verfasst von Lisa Wein und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, LMU Medizin, LMU University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany; SERIO-Registry,…. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CAR T-cell therapyCytokine release syndromeImmune checkpoint inhibitorImmunotherapy toxicityReal-world registryT-cell engager

Autor:innen und Institutionen

  • Department of Dermatology and Allergy, LMU Medizin, LMU University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany; SERIO-Registry, Germany; Comprehensive Cancer Center Munich (CCCM), Munich, Germany;…
  • Department of Dermatology and Allergy, LMU Medizin, LMU University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany; SERIO-Registry, Germany; Comprehensive Cancer Center Munich (CCCM), Munich, Germany.
  • Comprehensive Cancer Center Munich (CCCM), Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Department of Dermatology and Allergy, LMU Medizin, LMU University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany; SERIO-Registry, Germany; Institute of Anthropology Francisc I. Rainer, Romanian Acade…
  • Department of Dermatology and Allergy, LMU Medizin, LMU University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany; SERIO-Registry, Germany.
  • Department of Dermatology and Allergy, LMU Medizin, LMU University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

Förderung

  • Bundesministerium für Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund

Zitieren

APA

Wein, L., Ertl, C., Rejeski, K., David-Rus, R., Kong-Bild, M., Pusl, R., Frölich, L., Tomsitz, D., von Baumgarten, L., Subklewe, M., & Heinzerling, L. (2026). Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies. European Journal of Cancer, 249, 117817. https://doi.org/10.1016/j.ejca.2026.117817

Vancouver

Wein L, Ertl C, Rejeski K, David-Rus R, Kong-Bild M, Pusl R, et al. Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies. European Journal of Cancer. 2026;249:117817. doi:10.1016/j.ejca.2026.117817

BibTeX
@article{Wein2026,
  author = {Wein, Lisa and Ertl, Carolin and Rejeski, Kai and David-Rus, Richard and Kong-Bild, Mingzi and Pusl, Rebecca and Frölich, Lisa and Tomsitz, Dirk and von Baumgarten, Louisa and Subklewe, Marion and Heinzerling, Lucie},
  title = {Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {249},
  pages = {117817},
  doi = {10.1016/j.ejca.2026.117817}
}
Kostenlos starten →